IBD barriers across the continents: a continent-specific analysis: Latin America

Latin America (LATAM) is a large region comprising 47 countries and territories. Each one carries a different cultural and historical background, diverse political systems, and a particular approach to healthcare management. There is a lack of high-quality data on the epidemiology of inflammatory bowel diseases (IBD) in this region, including broad and detailed information about the penetration of biological and advanced therapies as treatment strategies. From an IBD perspective, patients experience, in general, fragmentations and inequities in the healthcare systems, with different and usually delayed access to qualified health services. This review explores the barriers to accessing IBD care throughout LATAM. The authors compiled data from multiple sources, such as studies focusing on epidemiology, biological penetration, and surgical rates. In addition, overall access to IBD treatments was assessed through a questionnaire distributed to physicians in LATAM via email and direct messaging to capture local perspectives.

Automated summary

Latin America is a diverse region with 47 countries and territories, each with its own cultural, historical, and healthcare management differences. However, there is a lack of high-quality data on inflammatory bowel diseases (IBD) in this region, including information on the use of biological and advanced therapies. Patients with IBD in Latin America face barriers and inequities in accessing healthcare services. This review examines the obstacles to IBD care in Latin America and gathers data from various sources, including epidemiological studies and surveys of healthcare professionals in the region.